Trending...
- Tim O'Loughlin Appointed Chief Executive Officer of Vantiva and Co-opted as a Director of the Board
- Local SF Conservatory Pre-College Student Selected to Perform at Carnegie Hall
- project44 Secures Top Spot Across 12 Categories in G2 Fall 2024 Grid Reports
FAYETTEVILLE, Ark. - illiNews -- Lineus Medical announces a significant reduction in price of nearly 15% for its flagship product, SafeBreak Vascular, in the United States. After creating a new device classification with the FDA and becoming the first break-away device available for IV lines in the US, SafeBreak Vascular was first released with a list price of $6.90. Since its release, increased sales volume and concentrated efforts toward manufacturing efficiencies support a price adjustment with a new list price of $5.90, effective on September 1st, 2024.
SafeBreak Vascular is the only break-away device for IV lines proven to reduce IV complications1. When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When SafeBreak separates, valves on both ends of the device close preventing medicine spills from the pump and blood loss from the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile SafeBreak is installed, and the patent's infusion is restarted. Patients avoid additional needlesticks, nurses save time, and hospitals save money1.
More on illi News
"A large focus of our strategy is maximizing our economic value proposition for the hospital." Lineus Medical's Vice President of Sales, Larry Hayes comments, "Reducing our price allows for both current and new accounts to take advantage of cost savings, and in doing so, we are making it easier for hospitals to invest in improved vascular access care for their patients."
Vance Clement, CEO of Lineus Medical, stated, "Inflation is hitting everyone, and we are all used to prices going up. This is especially true in healthcare, where prices never go down. However, SafeBreak, which is proudly made in the USA, is changing that. As we continue to grow, we will keep investing in manufacturing so that we can lower the cost of SafeBreak again in the future."
Lineus Medical is committed to improving patient safety and advancing vascular access care and believes that this price reduction is another important step in our mission to remove the pains associated with medical lines. Anyone interested in SafeBreak Vascular's price reduction can visit our website www.lineusmed.com to learn more.
More on illi News
About Lineus Medical
Lineus Medical is the developer of a break-away technology that is proven to reduce IV restarts and IV complications1. Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn.
SafeBreak Vascular is the only break-away device for IV lines proven to reduce IV complications1. When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When SafeBreak separates, valves on both ends of the device close preventing medicine spills from the pump and blood loss from the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile SafeBreak is installed, and the patent's infusion is restarted. Patients avoid additional needlesticks, nurses save time, and hospitals save money1.
More on illi News
- Get an Online Handicap Parking Placard in Los Angeles: HandicapMD.com Revolutionizes Access to Handicap Placards
- 10th Annual Benefit for Women Veterans: 100 Pretty Purses to Mark 2,000 Lives Changed Since 2015
- Carl Resnick joins Flexible Plan Investments as vice president of national sales
- Project EverGreen Creates A Cooler, Greener Future for New York City's Joe Holzka Community Garden
- Gravesider Mobile App Wants to Hire Actors to Play Dead
"A large focus of our strategy is maximizing our economic value proposition for the hospital." Lineus Medical's Vice President of Sales, Larry Hayes comments, "Reducing our price allows for both current and new accounts to take advantage of cost savings, and in doing so, we are making it easier for hospitals to invest in improved vascular access care for their patients."
Vance Clement, CEO of Lineus Medical, stated, "Inflation is hitting everyone, and we are all used to prices going up. This is especially true in healthcare, where prices never go down. However, SafeBreak, which is proudly made in the USA, is changing that. As we continue to grow, we will keep investing in manufacturing so that we can lower the cost of SafeBreak again in the future."
Lineus Medical is committed to improving patient safety and advancing vascular access care and believes that this price reduction is another important step in our mission to remove the pains associated with medical lines. Anyone interested in SafeBreak Vascular's price reduction can visit our website www.lineusmed.com to learn more.
More on illi News
- CCHR Wants Increased Consumer Awareness About "Prescriptions for Violence"
- The Grossman Group Releases New eBook with Essential Tips for Driving Culture Change
- The Giant is Coming to Las Vegas: A Landmark Blending Art, Entertainment & Blockchain for an Unforgettable Experience!
- Nurturing Healthy Smiles Through Little Mouth Program
- Experience the Future of Digital Textbook with KITABOO at FBF 2024 and Win an iPad Daily!
About Lineus Medical
Lineus Medical is the developer of a break-away technology that is proven to reduce IV restarts and IV complications1. Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn.
Source: Lineus Medical
0 Comments
Latest on illi News
- Sensorium Therapeutics Highlights Promising Data on Lead Assets Targeting Anxiety & Epilepsy at Neuroscience 2024
- Mayor Brandon Johnson and World Business Chicago Lead High-level Business Mission to London, Advancing Economic Growth Opportunities for Chicago
- Bug Busters Celebrates 40 Years in the Pest Control Industry
- Made-in-the USA Manufacturer, Jeron Electronic Systems, has Experienced No Supply Delays for Shipping Nurse Call Systems and Area of Rescue Systems
- National Minority Health Association and Cell-Ed Announce Upcoming Webinar: Empowering Caregivers Through Innovative Training Programs
- Free 6-Month Premium Matrimonial Membership Now Available on IndoMarry.com
- Various Measures Introduced to and Approved by The Chicago City Council
- NEMTAC Announces Public Comment Period for the NEMTAC 3001-202X Transportation Specialist Education Draft Standard
- Dr. Stephen Shainbart, PHD, Highlights 5 Reasons to Discuss Family Therapy and Couples Counseling in Buffalo, NY
- Restoration Specialists Celebrates a Successful 2024 and Strong Q4
- Purple Union C-Murder Supporting Angola Prisoners in Their Fight for Basic Human Rights Through Labor Strike
- OpsVeda Is Now Available Through AWS Marketplace
- project44 Secures Top Spot Across 12 Categories in G2 Fall 2024 Grid Reports
- Circumference Group Acquires Majority Stake in Visionary Integration Professionals
- Tim O'Loughlin Appointed Chief Executive Officer of Vantiva and Co-opted as a Director of the Board
- The Champagne Connection Podcast: Healing Trauma and Finding Inner Peace with Radhavi Riom
- TN Nursery Gears Up for Busy Fall Shipping Season with Nationwide Fast Shipping, Low Grower Prices, and Storewide Deals
- Mayor Brandon Johnson and the City Of Chicago Announce $1.5 Billion Refinancing Plan to achieve $110 Million in Debt Savings
- Jazz Artist Bob Holz Signs With SoVibe Entertainment Plus Album Review In September 2024 Issue Of Downbeat Magazine
- 4-Star Gold Coast Hotel Showcases Chicago Artist's Watercolors